Sponsor Dossier
Pharmaco
Sponsor Dossier for Pharmaco. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ACIMAX
- Brand: ANAFRANIL
- Brand: ANEXATE
- Brand: CYMEVENE
- Brand: DILATREND
- Brand: HYPNOVEL
- Brand: KONAKION MM
- Brand: LARIAM
- Device (sponsor): Dental suction system cannula, single-use
- Device (sponsor): Self-care monitoring web-based application software
- Device (sponsor): Dental solution, cleansing
- Device (sponsor): Invasive interstitial-fluid glucose monitoring system
- Device (sponsor): Hypodermic needle, single-use, sterile
- Device (sponsor): Electrode, electrocardiograph, single use
- Device (sponsor): Dental coating, tooth-desensitizing, professional
- Device (sponsor): Crown/bridge, temporary, polymer based
- Device (sponsor): Denture reliner, elastic, long-term
- Device (sponsor): Prosthesis priming agent
- Device (sponsor): Dental composite resin kit
- Device (sponsor): Dental bonding agent, polymer based
- Device (sponsor): Resin-composite dental cement
- Device (sponsor): Impression material, dental, silicone
- Device (sponsor): Impression material, dental, silicone
- Device (sponsor): Two-component dental material applicator, manual
- Device (sponsor): Adhesive, dental impression
- Device (sponsor): Dental material mixing nozzle, non-sterile
- Device (sponsor): Dental impression material syringe, single-use
- Device (sponsor): Mixer, dental, impression material
- Device (sponsor): Instrument/analyser IVDs
- Device (sponsor): Clinical chemistry substrate IVDs
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Blood lancet, single-use
- Device (sponsor): Clinical chemistry substrate IVDs
- Device (sponsor): Cuff, tourniquet, single use
- Device (sponsor): Lancet, automatic
- Device (sponsor): Syringe, Syringe, hypodermic, metered delivery, retractable needle
- Device (sponsor): Hypodermic needle, single-use, sterile
About
Pharmaco is an Other Incorporated Entity with ABN 89 113 383 501, registered in Australia and currently active.
Portfolio
Pharmaco holds 22 brands on the ARTG, of which 20 are indexable and have Product Information on file. Eleven brands in the portfolio are PBS-listed, one brand has a PBAC outcome on record, and one brand has an AusPAR on record. Notable brands include ACIMAX, ANAFRANIL, ANEXATE, CYMEVENE, DILATREND, HYPNOVEL, KONAKION MM, LARIAM, LEXOTAN, LOSEC, OMEPRAL, and OTODEX.
Therapeutic focus —
Infectious Disease: 8 brands — Neurology: 4 brands — Cardiology: 3 brands — Pain Management: 2 brands — Psychiatry: 1 brand — Ophthalmology: 1 brand — Oncology: 1 brand — Endocrinology: 1 brand — Other: 1 brand
PBS footprint
Eleven of Pharmaco's brands are PBS-listed, with the portfolio's latest PBS schedule date being 1 May 2026.
Regulatory activity
The most recent PBAC outcome for Pharmaco was recorded on 1 July 2009, covering one brand. The most recent AusPAR was published on 8 September 2015, relating to one brand.